ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Alternatives
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Disruptive Technology
    • Dividend
    • Dual Impact
    • Emerging Markets
    • Energy Infrastructure
    • ESG
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Fixed Income
    • Free Cash Flow
    • Future ETFs
    • Global Diversification
    • Gold & Silver Investing
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Megatrends
    • Modern Alpha
    • Multi-Asset
    • Night Effect
    • Portfolio Strategies
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Thematic Investing
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
    • ETF Data for Journalists
    • ETF Nerds
  • Research
    • First Bitcoin ETF
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF Trends on Videos
    • ETF Trends on Podcasts
    • ETF Prime Podcast
  • Company
    • About Us
    • Swag Store
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Disruptive Technology Channel
  2. EXAS Nears Key Buy Signal in ARKG
Disruptive Technology Channel
Share

EXAS Nears Key Buy Signal in ARKG

Nick Peters-GoldenJan 11, 2023
2023-01-11

There are a lot of reasons to be skeptical of tech investing right now since last year’s broad market selloff — just how far is the Fed planning to go with rising rates this year, anyway? Still, there is a place for a smart tech slice in investors’ portfolios, especially in companies disrupting and innovating in life sciences, like Exact Sciences (EXAS), which has helped the active biotech ETF, the ARK Genomic Revolution ETF (ARKG A-), see some notable returns over the last week.

EXAS had already been riding high from news at the end of 2022 that its well-known colon cancer screening test Cologuard outperformed rivals. It’s exploded in price by 32.5% over the last five days thanks to strong preliminary revenues for the fourth quarter that ended on December 31 and is a great example of the kind of biotech firm that ARKG goes after according to its active approach.

EXAS’s price jump takes it well above both its 50-day and 200-day Simple Moving Averages (SMAs), with the two indicators approaching a key buy signal in the form of a “golden cross” in which the 50-day SMA moves above the 200-day metric.

ARKG invests in companies that, like EXAS, benefit from advances in in gene editing, genetic therapy, and molecular diagnostics. The active ETF holds EXAS as its largest-weighted stock at 13.3%, followed by Pacific Biosciences of California (PACB) and Ionis Pharmaceuticals (IONS) at 5.3% and 5.1%, respectively.

The active biotech ETF charges a 75 basis point fee for its approach, and in part thanks to EXAS, it has returned 9.5% over one week, the second-best performance of the entire ARK ETF suite. It has also taken in $31 million in one-week net inflows, as investors buy in to its biotech investment case.

Finding the right tech play this year won’t be easy with so many tech names heavily exposed to the U.S. and the dual challenge of rising rates and a possible recession. Still, there are longer-term plays to be found in disruptive innovation-focused companies in biotech, with ARKG a strategy to watch for investors drawn to the possibilities offered by genetic advancements.

For more news, information, and analysis, visit our Disruptive Technology Channel.

Loading Articles...
Help & Info
  • Contact Us
Tools
  • ETF Screener
  • ETF Analyzer
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Performance Visualizer
  • ETF Database Model Portfolios
  • ETF Database Realtime Ratings
  • ETF Database Pro
More Tools
  • ETF Launch Center
  • Financial Advisor & RIA Center
  • ETF Database RSS Feed
Explore ETFs
  • ETF News
  • ETF Picks of the Month
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Best ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Legal
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.
Follow ETF Database
Follow ETF Database

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X